Eva Wang

All read papers (50)

STAR: ultrafast universal RNA-seq aligner

Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P, Chaisson M, Gingeras TR.

Bioinformatics · 2013

2.8/5

Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry

Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K.

Acta Neuropathol · 2006

2.3/5

Innate and adaptive immune cells in the tumor microenvironment

Gajewski TF, Schreiber H, Fu YX.

Nat Immunol · 2013

3.5/5

NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control

Böttcher JP, Bonavita E, Chakravarty P, Blees H, Cabeza-Cabrerizo M, Sammicheli S, Rogers NC, Sahai E, Zelenay S, Reis e Sousa C

Cell · 2018

3.8/5

Alzheimer's disease is a synaptic failure

Selkoe DJ.

Science · 2002

2.5/5

Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation

Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J, Guillozet-Bongaarts A, Ohno M, Disterhoft J, Van Eldik L, Berry R, Vassar R.

J Neurosci · 2006

3.0/5

Predicting effective microRNA target sites in mammalian mRNAs

Agarwal V, Bell GW, Nam JW, Bartel DP.

Elife · 2015

3.3/5

Spatial reconstruction of single-cell gene expression data

Satija R, Farrell JA, Gennert D, Schier AF, Regev A.

Nat Biotechnol · 2015

3.3/5

Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy

Sharma P, Hu-Lieskovan S, Wargo JA, Ribas A.

Cell · 2017

2.3/5

GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit

Pronk S, Páll S, Schulz R, Larsson P, Bjelkmar P, Apostolov R, Shirts MR, Smith JC, Kasson PM, van der Spoel D, Hess B, Lindahl E.

Bioinformatics · 2013

3.0/5

Microglia Function in the Central Nervous System During Health and Neurodegeneration

Colonna M, Butovsky O.

Annu Rev Immunol · 2017

1.8/5

Loop-mediated isothermal amplification of DNA

Notomi T, Okayama H, Masubuchi H, Yonekawa T, Watanabe K, Amino N, Hase T.

Nucleic Acids Res · 2000

3.0/5

Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing

Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Swaminathan B.

J Clin Microbiol · 1995

2.8/5

Expanded encyclopaedias of DNA elements in the human and mouse genomes

ENCODE Project Consortium, Moore JE, Purcaro MJ, Pratt HE, Epstein CB, Shoresh N, Adrian J, Kawli T, Davis CA, Dobin A, Kaul R, Halow J, Van Nostrand EL, Freese P, Gorkin DU, Shen Y, He Y, Mackiewicz M, Pauli-Behn F, Williams BA, Mortazavi A, Keller CA, Zhang XO, Elhajjajy SI, Huey J, Dickel DE, Snetkova V, Wei X, Wang X, Rivera-Mulia JC, Rozowsky J, Zhang J, Chhetri SB, Zhang J, Victorsen A, White KP, Visel A, Yeo GW, Burge CB, Lécuyer E, Gilbert DM, Dekker J, Rinn J, Mendenhall EM, Ecker JR, Kellis M, Klein RJ, Noble WS, Kundaje A, Guigó R, Farnham PJ, Cherry JM, Myers RM, Ren B, Graveley BR, Gerstein MB, Pennacchio LA, Snyder MP, Bernstein BE, Wold B, Hardison RC, Gingeras TR, Stamatoyannopoulos JA, Weng Z.

Nature · 2020

2.5/5

Comprehensive molecular portraits of human breast tumours

Cancer Genome Atlas Network.

Nature · 2012

2.5/5

Alzheimer's disease

Scheltens P, De Strooper B, Kivipelto M, Holstege H, Chételat G, Teunissen CE, Cummings J, van der Flier WM.

Lancet · 2021

2.3/5

Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients

Herbst RS, Soria JC, Kowanetz M, Fine GD, Hamid O, Gordon MS, Sosman JA, McDermott DF, Powderly JD, Gettinger SN, Kohrt HE, Horn L, Lawrence DP, Rost S, Leabman M, Xiao Y, Mokatrin A, Koeppen H, Hegde PS, Mellman I, Chen DS, Hodi FS.

Nature · 2014

3.0/5

Complement and microglia mediate early synapse loss in Alzheimer mouse models

Hong S, Beja-Glasser VF, Nfonoyim BM, Frouin A, Li S, Ramakrishnan S, Merry KM, Shi Q, Rosenthal A, Barres BA, Lemere CA, Selkoe DJ, Stevens B.

Science · 2016

1.5/5

The hallmarks of aging

López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G.

Cell · 2013

3.5/5

Transcription Factors Activate Genes through the Phase-Separation Capacity of Their Activation Domains

Boija A, Klein IA, Sabari BR, Dall'Agnese A, Coffey EL, Zamudio AV, Li CH, Shrinivas K, Manteiga JC, Hannett NM, Abraham BJ, Afeyan LK, Guo YE, Rimel JK, Fant CB, Schuijers J, Lee TI, Taatjes DJ, Young RA.

Cell · 2018

3.0/5

DNA targeting specificity of RNA-guided Cas9 nucleases

Hsu PD, Scott DA, Weinstein JA, Ran FA, Konermann S, Agarwala V, Li Y, Fine EJ, Wu X, Shalem O, Cradick TJ, Marraffini LA, Bao G, Zhang F.

Nat Biotechnol · 2013

3.8/5

Development and applications of CRISPR-Cas9 for genome engineering

Hsu PD, Lander ES, Zhang F.

Cell · 2014

3.0/5

Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion

Dong H, Strome SE, Salomao DR, Tamura H, Hirano F, Flies DB, Roche PC, Lu J, Zhu G, Tamada K, Lennon VA, Celis E, Chen L.

Nat Med · 2002

3.0/5

CHOPCHOP v3: expanding the CRISPR web toolbox beyond genome editing

Labun K, Montague TG, Krause M, Torres Cleuren YN, Tjeldnes H, Valen E.

Nucleic Acids Res · 2019

3.3/5

GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases

Tsai SQ, Zheng Z, Nguyen NT, Liebers M, Topkar VV, Thapar V, Wyvekens N, Khayter C, Iafrate AJ, Le LP, Aryee MJ, Joung JK.

Nat Biotechnol · 2015

3.5/5

Elements of cancer immunity and the cancer-immune set point

Chen DS, Mellman I.

Nature · 2017

2.3/5

Extracellular vesicles: exosomes, microvesicles, and friends

Raposo G, Stoorvogel W.

J Cell Biol · 2013

2.5/5

Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity

Ran FA, Hsu PD, Lin CY, Gootenberg JS, Konermann S, Trevino AE, Scott DA, Inoue A, Matoba S, Zhang Y, Zhang F.

Cell · 2013

1.8/5

Genetic screens in human cells using the CRISPR-Cas9 system

Wang T, Wei JJ, Sabatini DM, Lander ES.

Science · 2014

3.3/5

Prions

Prusiner SB.

Proc Natl Acad Sci U S A · 1998

3.0/5

High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells

Fu Y, Foden JA, Khayter C, Maeder ML, Reyon D, Joung JK, Sander JD.

Nat Biotechnol · 2013

3.3/5

The Genotype-Tissue Expression (GTEx) project

GTEx Consortium.

Nat Genet · 2013

3.8/5

Cholangiocarcinoma 2020: the next horizon in mechanisms and management

Banales JM, Marin JJG, Lamarca A, Rodrigues PM, Khan SA, Roberts LR, Cardinale V, Carpino G, Andersen JB, Braconi C, Calvisi DF, Perugorria MJ, Fabris L, Boulter L, Macias RIR, Gaudio E, Alvaro D, Gradilone SA, Strazzabosco M, Marzioni M, Coulouarn C, Fouassier L, Raggi C, Invernizzi P, Mertens JC, Moncsek A, Ilyas SI, Heimbach J, Koerkamp BG, Bruix J, Forner A, Bridgewater J, Valle JW, Gores GJ.

Nat Rev Gastroenterol Hepatol · 2020

3.0/5

PD-1 and its ligands in tolerance and immunity

Keir ME, Butte MJ, Freeman GJ, Sharpe AH.

Annu Rev Immunol · 2008

2.0/5

A statistical framework for SNP calling, mutation discovery, association mapping and population genetical parameter estimation from sequencing data

Li H.

Bioinformatics · 2011

3.0/5

Inferring tumour purity and stromal and immune cell admixture from expression data

Yoshihara K, Shahmoradgoli M, Martínez E, Vegesna R, Kim H, Torres-Garcia W, Treviño V, Shen H, Laird PW, Levine DA, Carter SL, Getz G, Stemke-Hale K, Mills GB, Verhaak RG.

Nat Commun · 2013

3.0/5

Profiling of complex microbial populations by denaturing gradient gel electrophoresis analysis of polymerase chain reaction-amplified genes coding for 16S rRNA

Muyzer G, de Waal EC, Uitterlinden AG.

Appl Environ Microbiol · 1993

2.8/5

Circ-ZNF609 Is a Circular RNA that Can Be Translated and Functions in Myogenesis

Legnini I, Di Timoteo G, Rossi F, Morlando M, Briganti F, Sthandier O, Fatica A, Santini T, Andronache A, Wade M, Laneve P, Rajewsky N, Bozzoni I.

Mol Cell · 2017

3.3/5

Cancer immunotherapy using checkpoint blockade

Ribas A, Wolchok JD.

Science · 2018

2.3/5

Reactive astrocyte nomenclature, definitions, and future directions

Escartin C, Galea E, Lakatos A, O'Callaghan JP, Petzold GC, Serrano-Pozo A, Steinhäuser C, Volterra A, Carmignoto G, Agarwal A, Allen NJ, Araque A, Barbeito L, Barzilai A, Bergles DE, Bonvento G, Butt AM, Chen WT, Cohen-Salmon M, Cunningham C, Deneen B, De Strooper B, Díaz-Castro B, Farina C, Freeman M, Gallo V, Goldman JE, Goldman SA, Götz M, Gutiérrez A, Haydon PG, Heiland DH, Hol EM, Holt MG, Iino M, Kastanenka KV, Kettenmann H, Khakh BS, Koizumi S, Lee CJ, Liddelow SA, MacVicar BA, Magistretti P, Messing A, Mishra A, Molofsky AV, Murai KK, Norris CM, Okada S, Oliet SHR, Oliveira JF, Panatier A, Parpura V, Pekna M, Pekny M, Pellerin L, Perea G, Pérez-Nievas BG, Pfrieger FW, Poskanzer KE, Quintana FJ, Ransohoff RM, Riquelme-Perez M, Robel S, Rose CR, Rothstein JD, Rouach N, Rowitch DH, Semyanov A, Sirko S, Sontheimer H, Swanson RA, Vitorica J, Wanner IB, Wood LB, Wu J, Zheng B, Zimmer ER, Zorec R, Sofroniew MV, Verkhratsky A.

Nat Neurosci · 2021

3.3/5

CRISPR-Cas systems for editing, regulating and targeting genomes

Sander JD, Joung JK.

Nat Biotechnol · 2014

3.8/5

Efficient genome editing in zebrafish using a CRISPR-Cas system

Hwang WY, Fu Y, Reyon D, Maeder ML, Tsai SQ, Sander JD, Peterson RT, Yeh JR, Joung JK.

Nat Biotechnol · 2013

3.3/5

COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses

Shereen MA, Khan S, Kazmi A, Bashir N, Siddique R.

J Adv Res · 2020

2.5/5

Dementia prevention, intervention, and care: 2020 report of the Lancet Commission

Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, Brayne C, Burns A, Cohen-Mansfield J, Cooper C, Costafreda SG, Dias A, Fox N, Gitlin LN, Howard R, Kales HC, Kivimäki M, Larson EB, Ogunniyi A, Orgeta V, Ritchie K, Rockwood K, Sampson EL, Samus Q, Schneider LS, Selbæk G, Teri L, Mukadam N.

Lancet · 2020

4.0/5

CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes

Gilbert LA, Larson MH, Morsut L, Liu Z, Brar GA, Torres SE, Stern-Ginossar N, Brandman O, Whitehead EH, Doudna JA, Lim WA, Weissman JS, Qi LS.

Cell · 2013

3.0/5

The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups

Curtis C, Shah SP, Chin SF, Turashvili G, Rueda OM, Dunning MJ, Speed D, Lynch AG, Samarajiwa S, Yuan Y, Gräf S, Ha G, Haffari G, Bashashati A, Russell R, McKinney S, METABRIC Group, Langerød A, Green A, Provenzano E, Wishart G, Pinder S, Watson P, Markowetz F, Murphy L, Ellis I, Purushotham A, Børresen-Dale AL, Brenton JD, Tavaré S, Caldas C, Aparicio S.

Nature · 2012

3.8/5

Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9

Doench JG, Fusi N, Sullender M, Hegde M, Vaimberg EW, Donovan KF, Smith I, Tothova Z, Wilen C, Orchard R, Virgin HW, Listgarten J, Root DE.

Nat Biotechnol · 2016

3.8/5

Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia

Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J, van Swieten JC, Seelaar H, Dopper EG, Onyike CU, Hillis AE, Josephs KA, Boeve BF, Kertesz A, Seeley WW, Rankin KP, Johnson JK, Gorno-Tempini ML, Rosen H, Prioleau-Latham CE, Lee A, Kipps CM, Lillo P, Piguet O, Rohrer JD, Rossor MN, Warren JD, Fox NC, Galasko D, Salmon DP, Black SE, Mesulam M, Weintraub S, Dickerson BC, Diehl-Schmid J, Pasquier F, Deramecourt V, Lebert F, Pijnenburg Y, Chow TW, Manes F, Grafman J, Cappa SF, Freedman M, Grossman M, Miller BL.

Brain · 2011

1.8/5

A view on drug resistance in cancer

Vasan N, Baselga J, Hyman DM.

Nature · 2019

3.3/5

TIMER2.0 for analysis of tumor-infiltrating immune cells

Li T, Fu J, Zeng Z, Cohen D, Li J, Chen Q, Li B, Liu XS.

Nucleic Acids Res · 2020

2.8/5